1 / 26

Yale OAIC Overview

Yale OAIC Overview. YALE OAIC Theme. Investigation of multifactorial geriatric health conditions single conditions resulting from multiple contributing factors or affecting multiple health outcomes multiple conditions occurring simultaneously . Subtheme

gay
Télécharger la présentation

Yale OAIC Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Yale OAIC Overview

  2. YALE OAIC Theme Investigation of multifactorial geriatric health conditions • single conditions resulting from multiple contributing factors or affecting multiple health outcomes • multiple conditions occurring simultaneously Subtheme • advance the science of clinical decision making in the face of trade-offs and multiple competing outcomes

  3. Administrative Relationships of Yale Program on Aging and OAIC to Institution

  4. Three geriatric conditions—muscle weakness, slow gait, and depression, were associated with hospital admission after heart failure diagnosis, after accounting for other relevant demographic, social, and clinical factors. Geriatric conditions are important, and potentially modifiable, risk factors for hospital admission in heart failure that should be routinely assessed at the time of heart failure diagnosis.

  5. SILVER-AMI • NIH/NHLBI R01 HL115295 • 5 year direct costs: $7.2M • PI: Sarwat Chaudhry, M.D., Pepper Scholar and Beeson Scholar • Observational study of 3000 patients 75+ years hospitalized with acute myocardial infarction (AMI) • Goal: develop & validate risk models for 6-month hospital readmission, mortality, and decline in health status • Hypothesis: currently available risk models can be improved by incorporating geriatric conditions – impairments in cognition, muscle strength, gait, vision & hearing

  6. If validated in future cohorts, these clinical features with bacteriuria plus pyuria may serve as an evidence-based clinical definition of UTI to assist in management decisions.

  7. The CRANNY Study • CRANberry capsules for prevention of UTI in Nursing homes at Yale • NIA-funded RCT, 05/12-04/16, total costs: $2.6M • Primary hypothesis: 2 cranberry capsules/day will be associated with 33% reduction in occurrence of episodes of bacteriuria plus pyuria over 12 months, compared with placebo • Sample size: 180 • Urine specimens obtained at baseline and every 2 months • Urinary tract specific symptoms assessed at each time point • Secondary outcomes: symptomatic UTI, hospitalization, death, antibiotic prescriptions, resistant organisms

  8. Figure Respiratory Impairment in Older PersonsWhen Less Means More Carlos A. Vaz Fragoso, MD, Thomas M. Gill, MD, Gail McAvay, PhD, Philip H. Quanjer, MD, PhD, Peter H. Van Ness, PhD, MPH and John Concato, MD American Journal of Medicine Volume 126, Issue 1, Pages 49-57 (January 2013) A novel Z-score approach, pioneered by Yale OAIC investigators, is more clinically meaningful in identifying older persons with respiratory impairment (including COPD) than GOLD, the current standard. EurRespirJ, 2012; Am J Med, 2012; Am J Med, 2013

  9. 2012

  10. Aging Lung Initiative • LIFE Study • Spirometry Reading Center • Blood RNA Biorepository: R01 under review • NIA Program Project application • to investigate the pathogenesis, prevention, and treatment of COPD

  11. Patient Preferences for Deactivation of Implantable Cardioverter-Defibrillators John A. Dodson, MD; Terri R. Fried, MD; Peter H. Van Ness, PhD, MPH; Nathan E. Goldstein, MD; Rachel Lampert, MD JAMA Intern Med; Volume 173, Issue 5, Pages 377-379 (March 11, 2013) In a survey of 95 patients with implantable cardioverter-defibrillators (ICD), Yale OAIC investigators evaluated preferences for ICD deactivation. When faced with a series of 5 scenarios about deactivation, 71% of respondents (mean age, 71.4 y) answered “possibly” or “definitely yes” that they would want their ICD deactivated. The respondents demonstrated relatively poor understanding of the risks and benefits of the ICD. These findings highlight the importance of incorporating multiple patient-centered outcomes into advance care planning for ICD patients.

  12. New Pepper Scholars • Kasia Lipska, MD (Endocrinology) • decision-making and management in older persons with diabetes • 2013 GEMSSTAR recipient • Raimund Herzog, MD (Endocrinology) • role of multiple peripheral metabolites on cognitive performance • NIDDK K08 recipient • Joan Monin, PhD (Chronic Disease Epidemiology) • multiple chronic conditions and mutuality of care in late life marriage • 2013 NIA K01 recipient • Terrance Murphy, PhD (Geriatrics, Biostatistics Core) • Bayesian joint models of the time-dependent confounding between multiple medications and manifestations of delirium

  13. Recent/New Pilot Projects • Ifat Levy, PhD (Comparative Medicine and Neurobiology) • using behavioral economics and fMRI to develop a tool for the assessment of ambiguity aversion in medical decision making • Frank Slack, PhD (Molecular, Cellular & Developmental Biology) • using data and specimens from BLSA to identify miRNAs that could serve as biomarkers of longevity and aging in humans • Carlos Vaz Fragoso, MD (Geriatrics) • Dyspnea in Older Persons: A Multifactorial Geriatric Health Condition • Gerald Shadel, PhD (Pathology and Genetics) • Multifactorial Nature of Age-Related Hearing Loss in a Mouse Model of Mitochondrial Pathology

  14. Basic and Translational Program in Immunology of Aging • NIAID Contract: Impaired Human Innate Immune Cell Function in the Elderly and Immunosuppressed (E. Fikrig PI; A. Shaw and R. Montgomery Project Leaders) • elucidating age-related changes in human Toll-like receptor function • U19 AI: Immune Responses Defining Efficiency of Influenza Immunization(A. Shaw Project Leader) • project within Yale-based Center of the NIAID Human Immunology Project Consortium (D. HaflerPI) • computational biology approaches to influenza vaccine response signatures in young, older and frail adults • R01AG: Mechanisms of Dysregulated Immunity with Aging (D. Goldstein PI) • evaluating relationship between NKT cell inflammation and dendritic cell dysfunction in aged mice

  15. Basic and Translational Program in Immunology of Aging • R01AG: Aging and IL-7-mediated CD8 T Cell Survival (I. Kang PI) • investigating age-associated expansion of novel population of effector memory CD8 T cells in mouse models • U19 application: Innate and Adaptive Immune Control of Influenza Infection in Mice and Humans (A. Iwasaki PI; A. Shaw Human Subjects Core Leader) • will investigate age-associated changes in lung microbiome and in influenza-specific lung resident memory T cells in aged mice and older adults • R01 application: Circadian Rhythms and Immune Responses in Aging (R. Montgomery and A. Shaw PIs) • will investigate circadian variation in TLR function in aged humans and mice

  16. J Am GeriatrSoc, 2011 gerontological research is characterized by a number of challenges, such as missing data, recurrent events, multiple competing outcomes, and multifactorial interventions, all of which make its statistical analysis inherently complex

  17. A Method for Partitioning the Attributable Fraction of Multiple Time-Dependent Coexisting Risk Factors for an Adverse Health Outcome Haiqun Lin, MD, PhD, Heather G. Allore, PhD, Gail McAvay, PhD, Mary E. Tinetti, MD, Thomas M. Gill, MD, Cary P. Gross, MD, and Terrence E. Murphy, PhD American Journal of Public Health; Volume 103, Issue 1, Pages 177-182 (January 2013) Yale OAIC investigators developed and successfully implemented the longitudinal extension of the average attributable fraction (LE-AAF), which decomposes the total contributions of coexisting time-varying risk factors (e.g. diseases) on a timed occurrence of an outcome (e.g. death, hospitalization) into additive contributions from each risk factor whose sum is between 0 and 100% Am J Public Health, 2013; Stat Med & JAGS, 2012

  18. Cont Clin Trials 2012; 33:1124-31

  19. Testosterone Trial12 Field Centers University of Washington Boston University University of Minnesota Yale University Albert Einstein Northwestern University University of Pennsylvania University of Pittsburgh UCLA University of Alabama UC-San Diego University of Florida Baylor University Coordinating Center Clinical Site N=800 – 1 yr treatment

  20. Recruitment and Attrition in Testosterone Trial Yale • ↵

  21. LIFE Main Study Field Centers MA CT CA PA IL NC LA FL N=1,635 - average FU=32.5 months

  22. LIFE Determination of Major Mobility Disability at 24 months  Yale 

  23. Future Directions • Roybal Center • Shock Center application • LIFE-ARISE prevention of AD • Multi-Modality Mobility Trial • EASE-HF

More Related